Cases & Deals

Mauna Kea completes IPO and raises €56.5 million on NYSE Euronext in Paris

Clients Mauna Kea Technologies

Jones Day advised Mauna Kea Technologies, a global medical device company focused on leading innovation in endomicroscopy, in connection with its IPO on the regulated market of NYSE Euronext in Paris, underwritten by Société Générale, Dexia Securities France, and Gilbert Dupont, in which the company raised €56.5 million (US$81.8 million).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.